Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Discovery & Development Drug Discovery, Digital Technologies, Vaccines, Translational Science, COVID-19

Tracking the Pandemic

Edward Mills, Vice President of Real-World Evidence and Senior Principal Scientist at Cytel.

“COVID-19 has created extreme uncertainties – a dearth of historical information combined with the need for safety, statistical rigor, and speed has prompted the rapid surge in the generation of clinical data,” says Edward Mills, Vice President of Real-World Evidence and Senior Principal Scientist at Cytel, a provider of advanced analytics and statistical software solutions to the life sciences sector. 

But the volume of new data being produced presents a significant problem: information is scattered across multiple platforms, making it challenging to comparatively measure treatment effects across trials. Attempting to pull this data into one platform, Cytel – in collaboration with the Bill and Melinda Gates Foundation – has created a global, open-access COVID-19 clinical trial tracker.

Read the full article now

Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE and always will be!

Login

Or register now - it’s free and always will be!

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine
Register

Or Login via Social Media

By clicking on any of the above social media links, you are agreeing to our Privacy Notice.

About the Author

Maryam Mahdi

Associate Editor

After finishing my degree, I envisioned a career in science communications. However, life took an unexpected turn and I ended up teaching abroad. Though the experience was amazing and I learned a great deal from it, I jumped at the opportunity to work for Texere. I'm excited to see where this new journey takes me!

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register